BridgeMD
New treatment option for HIV/AIDS
Official title Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement
ClinicalTrials.gov ID: NCT05509959
What this study is testing
- What it's testing
- A two-arm RCT will be conducted to test the efficacy of Women SHINE, a web-based trauma-informed peer navigation-social support intervention (Figure 2). A total of 360 women living with HIV/AIDS (WLHA) with a history of adulthood interpersonal violence who have been prescribed ART but are non-adherent (\< 90% ART adherent in the last 4 weeks) will be enrolled in the study.
- Time commitment: about 4 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Cisgender female
- Diagnosis of HIV by a physician, healthcare provider, or community health worker
- Aged 18 years or older
- Speaking and reading English or Spanish
- Adulthood experiences of interpersonal violence
You likely can't join if
- Unwillingness to participate in the intervention
- Transgender female
- No diagnosis of HIV by a physician, healthcare provider, or community health worker
- Aged less than 18 years
- Not speaking and reading English or Spanish
- Not currently prescribed ART
See the full eligibility criteria
- Cisgender female
- Diagnosis of HIV by a physician, healthcare provider, or community health worker
- Aged 18 years or older
- Speaking and reading English or Spanish
- Adulthood experiences of interpersonal violence
- Currently prescribed ART
- Self-report of \<90% past-month ART adherence
- Not currently participating in another adherence intervention
- Access to an internet browser
- Unwillingness to participate in the intervention
- Transgender female
- No diagnosis of HIV by a physician, healthcare provider, or community health worker
- Aged less than 18 years
- Not speaking and reading English or Spanish
- Not currently prescribed ART
- Self-report of \>= 90% past-month ART adherence
- Currently participating in another adherence intervention
- No access to an internet browser
- Cognitive impairment limiting the ability to provide informed consent
- Experiencing only childhood experiences of interpersonal violence
- Inability to safely participate in the study based on secondary screener
The study team makes the final eligibility decision.
Where it's taking place
- La Jolla, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include La Jolla, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.